Candel Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $100k | 15k | 6.93 |
| 2024-06-30 | $29k | 4.6k | 6.20 |
| 2022-12-31 | $630 | 352 | 1.79 |
| 2022-09-30 | $1.0k | 335 | 2.99 |
| 2021-12-31 | $7.0k | 866 | 8.08 |